The 18 important medicines that Australians are missing out on
Eighteen innovative medicines for cancer, mental illness and rare diseases approved overseas are unavailable in Australia, Medicines Australia warned. The lobby group says the complex approval process and low government reimbursement rates make the local market unattractive to pharmaceutical companies. Patients like Tina Powney, who needs a new IPAH treatment costing sixteen thousand dollars, cannot access these life-changing therapies.
Take it further — get the full app and never miss a moment of what's happening in Australia.
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
Published 19 Jul 2026, 19:00 UTC · Updated 19 Jul 2026, 19:11 UTC
Summary by OZbrief Editorial. Original report: SMH. Editorial policy · Corrections
Trending
- Breaking: Terence Donovan dies aged 90
- Salvation Army worker's medication error leads to resident's death
- Driver suffers medical episode, crashes into multiple vehicles on Sydney Harbour Bridge
- ‘Everyone's afraid to die’: Struggle to recruit soldiers in Ukraine turns violent
- Wallabies player ratings: How the men in gold performed
- New hotel in Victoria’s second-largest city has the best views in town



